The present disclosure provides certain tetrazole derivatives that are inhibitors of transient receptor potential ankyrin 1 (TRPA1), and are therefore useful for the treatment of diseases treatable by inhibition of TRPA1. Also provided are pharmaceutical compositions containing the same, and processes for preparing said compounds.
-
Paragraph 0255-0260
(2022/01/07)
Novel Thienopyrimidones
This invention relates to thienopyrimidinones and their use as inhibitors of TRPA1 activity, pharmaceutical compositions containing the same, and methods of using the same as agents for treatment and/or prevention of fibrotic diseases, inflammatory and auto-immune diseases and CNS-related diseases.
-
Paragraph 0171; 0207-0212
(2021/04/17)
HETEROARYL-ETHANOLAMINE DERIVATIVES AS ANTIVIRAL AGENTS
The present invention provides a compound of formula as described herein, which are useful as antiviral agents, in particular, as agents against viruses of the herpes family.
-
Page 48-49
(2010/02/09)
Pyridoquinoxaline antivirals
The present invention provides a compound of formula I or a pharmaceutically acceptable salt thereof wherein R1, R2 and R3 are as defined in the specification. The compounds are useful for the treatment of viral infections.
-
(2008/06/13)
More Articles about upstream products of 496879-84-6